Title: Beibei Li: Innovator in Complement Factor B Analogs
Introduction
Beibei Li is a notable inventor based in the United States. She has made significant contributions to the field of biotechnology, particularly in the development of complement factor B analogs. Her work focuses on innovative solutions for modulating complement pathways, which are crucial in various biological processes.
Latest Patents
Beibei Li holds a patent titled "Complement Factor B Analogs And Their Uses." This invention provides polypeptides that comprise a complement factor B analog. The patent also details various complement factor B analogs, including those with mutations of a free cysteine amino acid. These analogs, along with related methods, nucleic acids, and vectors, can be utilized to modulate a complement pathway or for the study and treatment of conditions related to this pathway. Although she currently has 0 patents, her research holds promise for future developments.
Career Highlights
Beibei Li is associated with Pharma Cinq, LLC, where she continues to advance her research in biotechnology. Her work is pivotal in exploring new therapeutic avenues that could benefit patients suffering from diseases linked to complement pathways.
Collaborations
Throughout her career, Beibei has collaborated with esteemed colleagues, including Changhung Chen and Michael Kaleko. These partnerships enhance the scope and impact of her research, fostering innovation in the field.
Conclusion
Beibei Li is an emerging inventor whose work on complement factor B analogs showcases her dedication to advancing biotechnology. Her contributions, although currently limited in patents, have the potential to lead to significant breakthroughs in medical treatments.